Prosecution Insights
Prosecution Insights
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (60%) |
| No statute on record | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GILL, RACHEL B | 1 | 65.6% | +27.7% |
| SUNSHINE, HANNAH LOUISE | 1 | 71.0% | +13.3% |
| KIRWIN, STEFANIE JOHANNA | 1 | 13.5% | +33.3% |
| REDDIG, PETER J | 1 | 58.0% | +40.0% |
| CHEN, STACY BROWN | 1 | 65.9% | +40.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18016538 | Methods and Compositions for Diagnosing and Treating Cancer | KIRWIN, STEFANIE JOHANNA | 65d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17841267 | COMBINATIONS OF FLAVIVIRUS PROTEINS, PEPTIDE SEQUENCES, EPITOPES, AND METHODS AND USES THEREOF | CHEN, STACY BROWN | 154d overdue |
| 18556612 | ENGINEERED ARENAVIRUS GLYCOPROTEIN COMPOSITIONS, METHODS AND USE THEREOF | GILL, RACHEL B | 8d |
| 18027338 | BATF AND IRF4 IN T CELLS AND CANCER IMMUNOTHERAPY | SUNSHINE, HANNAH LOUISE | 14d |
| 18016538 | Methods and Compositions for Diagnosing and Treating Cancer | KIRWIN, STEFANIE JOHANNA | 65d |
| 18047928 | COMPOSITIONS AND METHODS FOR LONG-LASTING GERMINAL CENTER RESPONSES TO A PRIMING IMMUNIZATION | REDDIG, PETER J | — |
| Art Unit | Apps |
|---|---|
| 1671 | 1 |
| 1647 | 1 |
| 1677 | 1 |
| 1646 | 1 |
| 1672 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18556612 | ENGINEERED ARENAVIRUS GLYCOPROTEIN COMPOSITIONS, METHODS AND USE THEREOF | GILL, RACHEL B | 1671 | Other | Non-Final OA | 8d | Pending | Oct 20, 2023 |
| 18027338 | BATF AND IRF4 IN T CELLS AND CANCER IMMUNOTHERAPY | SUNSHINE, HANNAH LOUISE | 1647 | §103 | Non-Final OA | 14d | Pending | Mar 20, 2023 |
| 18016538 | Methods and Compositions for Diagnosing and Treating Cancer | KIRWIN, STEFANIE JOHANNA | 1677 | §103 | Non-Final OA | 65d | Pending | Jan 17, 2023 |
| 18047928 | COMPOSITIONS AND METHODS FOR LONG-LASTING GERMINAL CENTER RESPONSES TO A PRIMING IMMUNIZATION | REDDIG, PETER J | 1646 | Other | Final Rejection | — | Pending | Oct 19, 2022 |
| 17841267 | COMBINATIONS OF FLAVIVIRUS PROTEINS, PEPTIDE SEQUENCES, EPITOPES, AND METHODS AND USES THEREOF | CHEN, STACY BROWN | 1672 | §103 | Non-Final OA | 154d overdue | Pending | Jun 15, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial